---
title: MagViT: Interpretable Multi-Magnification Transformers with Patient-Level Model Selection for Breast Histopathology
url: http://arxiv.org/abs/2608.16959v1
type: paper-summary
date: 2026-08-18
source_paper: 2026-08-16_18-20-40Z_MagViT_InterpretableMulti_MagnificationTransformer.md
generated_at: 2026-08-18 22:03
model: nvidia/nemotron-3-nano-4b
---

## Summary
This paper introduces MagViT, an interpretable multi-magnification transformer that combines four tissue magnifications to classify breast histopathology. The model achieves high patient-level accuracy on the BreakHis dataset and shows promising external transfer performance on BUSI and IDC. Grad-CAM visualizations confirm focus on diagnostically relevant regions.

## Key Takeaways
- MagViT uses a learnable gate to fuse four different magnifications (40X, 100X, 200X, 400X) while masking missing scales, enabling robust scale handling.  
- Patient-level five-fold cross-validation selects the most accurate architectural branch as the final model, prioritizing simplicity and patient‑level performance.  
- The framework attains a mean image accuracy of 0.9191 and patient accuracy of 0.9643 on BreakHis, with external transfer yielding comparable results on BUSI and IDC.

## Context
Medical imaging AI must balance high accuracy with interpretability to gain clinical trust. Multi‑scale feature fusion is essential because tissue morphology varies across magnification levels, yet most transformers treat scales uniformly. This work demonstrates that patient‑level selection can improve generalization beyond fixed architectures.

## Implications
For clinicians and researchers, MagViT offers a reproducible pipeline that reduces overfitting through patient‑specific model choice while maintaining a lightweight fusion pathway. The results suggest that interpretable multi‑magnification models could become standard in histopathology classification pipelines across institutions.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.16959v1)
